Literature DB >> 20155346

Minute localized malignant pleural mesothelioma coexisting with multiple adenocarcinomas.

Ryo Maeda1, Noritaka Isowa, Hideyuki Onuma, Hiroshi Miura, Hirokazu Tokuyasu, Yuji Kawasaki.   

Abstract

We report an extremely rare case of minute localized malignant pleural mesothelioma (LMPM) coexisting with multiple lung adenocarcinomas in a 64-year-old woman without a history of smoking or asbestos exposure. A computed tomography scan of the chest displayed total five ground-glass opacities in the lung. Transbronchial lung biopsy from a ground-glass opacity in the posterior segment revealed a bronchioloalveolar carcinoma. With a diagnosis of primary lung cancer, right upper lobectomy and wedge resection of the right lower lobe with systematic lymph node dissection was performed using video-assisted thoracoscopic surgery. Incidentally, a minute gray-white nodule measuring 6 mm was detected on the visceral pleural surface of the right upper lobe. The postoperative histological diagnosis was minute LMPM coexisting with multiple adenocarcinomas.

Entities:  

Mesh:

Year:  2010        PMID: 20155346     DOI: 10.1007/s11748-009-0466-5

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  7 in total

1.  Localized pleural malignant mesothelioma.

Authors:  S Erkiliç; I Sari; B Tunçözgür
Journal:  Pathol Int       Date:  2001-10       Impact factor: 2.534

2.  Localized malignant mesothelioma.

Authors:  Timothy Craig Allen; Philip T Cagle; Andrew M Churg; Thomas V Colby; Allen R Gibbs; Samuel P Hammar; Joseph M Corson; Margaret M Grimes; Nelson G Ordonez; Victor Roggli; William D Travis; Mark R Wick
Journal:  Am J Surg Pathol       Date:  2005-07       Impact factor: 6.394

3.  Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases.

Authors:  D M England; L Hochholzer; M J McCarthy
Journal:  Am J Surg Pathol       Date:  1989-08       Impact factor: 6.394

4.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Authors:  Nicholas J Vogelzang; James J Rusthoven; James Symanowski; Claude Denham; E Kaukel; Pierre Ruffie; Ulrich Gatzemeier; Michael Boyer; Salih Emri; Christian Manegold; Clet Niyikiza; Paolo Paoletti
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

Review 5.  Localized pleural malignant mesothelioma.

Authors:  Hiroshi Hirano; Shinichi Takeda; Yoshinori Sawabata; Yoshitomo Okumura; Hajime Maeda; Masaki Hanibuchi; Masami Ito; Masaru Nakagawa; Kunio Uematsu
Journal:  Pathol Int       Date:  2003-09       Impact factor: 2.534

6.  The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.

Authors:  R L Attanoos; A Griffin; A R Gibbs
Journal:  Histopathology       Date:  2003-09       Impact factor: 5.087

Review 7.  Localized malignant mesothelioma. A clinicopathologic and flow cytometric study.

Authors:  T B Crotty; J L Myers; A L Katzenstein; H D Tazelaar; S J Swensen; A Churg
Journal:  Am J Surg Pathol       Date:  1994-04       Impact factor: 6.394

  7 in total
  5 in total

1.  Localized malignant pleural mesothelioma.

Authors:  Takayuki Nakano; Rurika Hamanaka; Kana Oiwa; Kenei Nakazato; Ryota Masuda; Masayuki Iwazaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-05-08

2.  Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer.

Authors:  Weston Andrews; Subroto Paul; Navneet Narula; Nasser K Altorki
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-08-15

3.  Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases.

Authors:  Weigen Yao; Hanqing Yang; Guolai Huang; Yang Yan; Honglin Wang; Dongfang Sun
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 4.  Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.

Authors:  Alberto M Marchevsky; Andras Khoor; Ann E Walts; Andrew G Nicholson; Yu Zhi Zhang; Victor Roggli; John Carney; Anja C Roden; Henry D Tazelaar; Brandon T Larsen; Nolwenn LeStang; Lucian R Chirieac; Sonja Klebe; Ming-Sound Tsao; Marc De Perrot; Andrew Pierre; David M Hwang; Yin P Hung; Mari Mino-Kenudson; William Travis; Jennifer Sauter; Mary Beth Beasley; Françoise Galateau-Sallé
Journal:  Mod Pathol       Date:  2019-09-04       Impact factor: 7.842

5.  Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report.

Authors:  Masatoshi Yamazoe; Hiromi Tomioka; Takahiro Kamada; Masahiro Kaneko; Eiji Katsuyama
Journal:  Respir Med Case Rep       Date:  2018-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.